Comparing the current results to its competitors, Quantum Biopharma Ltd reported Revenue decrease in the 3 quarter 2025 year on year by 0 %, despite the revenue increase by the most of its competitors of 22.31 %, recorded in the same quarter.
Quantum Biopharma Ltd 's Comment on Competition and Industry Peers
Dogecoin operates in the cryptocurrency and blockchain sector, competing with alternative Layer-1 blockchains such as Ethereum, Solana, and Tron. Ethereum has experienced a decline in decentralized exchange (DEX) trading volume. Solana processes a significant number of monthly transactions and, along with Tron, leads in transaction fee revenue generation. Chainlink competes with other decentralized oracle networks and emerging technologies that may impact its market share. In the pharmaceutical industry, particularly for multiple sclerosis (MS) treatments, competition includes approved therapies such as ocrelizumab by Roche and siponimod by Novartis.
The Greater Cannabis Company Inc Share Performance
+17.17%
This Year
The Greater Cannabis Company Inc
Profile
The Greater Cannabis Company Inc's business model involves the cultivation, processing, and distribution of cannabis products. They aim to offer a wide range of cannabis-related goods to cater to the demands of both medical and recreational users.
Earth Science Tech Inc is a biotechnology company focused on developing and marketing innovative hemp cannabinoid-based products. Their business model revolves around research, development, manufacturing, and distribution of high-quality CBD and nutraceuticals for various industries, including the pharmaceutical and nutrition sectors.
Cv Sciences Inc operates through a business model focused on the production and sale of cannabidiol (CBD) based products. The company sources hemp for extraction, processes it into various CBD products, and distributes them through multiple channels, including online sales and retail partnerships. By leveraging the growing demand for CBD, Cv Sciences Inc aims to generate revenue and establish a market presence in the emerging health and wellness industry.
Cronos Group Inc operates as a vertically integrated cannabis company. Their business model revolves around cultivating, manufacturing, and distributing medical and recreational cannabis products. They aim to capture market share through their unique brands and partnerships with influential companies in various sectors.
Sources:
Quantum Biopharma Ltd’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Quantum Biopharma Ltd versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
